Prices for the first 10 drugs negotiated by Medicare fell from their initial net prices, but all drugs except one remained ...
Romy & Associates With just days left in the annual Medicare enrollment period, Benny Gomez, Medicare & Health Plan Educator ...
Key policies introduced over the past 45 years have brought new research organizations and investors into the pharmaceutical ...
Medicare’s drug benefit, known as Part D, will see major changes next year as part of a broader push to help the 50 ...
Pharma companies lobby for changes to Medicare drug price rules, targeting a four-year delay for pills' eligibility. Critics ...
Medicare carriers are dealing with disruption caused by increased usage, inflation and the impact of the Inflation Reduction ...
Congress recently made a number of changes to Medicare's "Part D" prescription drug benefit. The changes were part of President Joe Biden's signature legislation, the Inflation Reduction Act. The legi ...
The U.S. fiscal outlook has dramatically deteriorated since the last time we ran a surplus in 2001, and President Joe Biden — like Democratic and Republican presidents before him — ...
The Medicare Annual Election Period (AEP) is a critical time for beneficiaries to review and update their coverage. In a ...
With fewer Part D plans and a $2,000 out-of-pocket cap, beneficiaries must rethink their Medicare drug coverage for 2025.
The U.S. pharmaceutical industry is pushing to revamp the new law that allows Medicare to negotiate prices for its costliest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback